HSIC
Henry Schein, Inc.
Is HSIC Halal?
Dental and medical distribution — a permissible healthcare-supply business, with receivables and debt to screen.
What You Should Know
Henry Schein, Inc. distributes dental, medical and animal-health products and services. Its March 28, 2026 Form 10-Q reports assets of $11,304 million, interest-bearing debt of $3,408 million, cash and short-term investments of $138 million, receivables of $1,719 million and quarterly revenue of $3,368 million. Debt/assets is 30.15%, liquidity/assets is 1.22% and receivables-plus-cash/assets is 16.43%; the known asset-based ratios pass. Disclosed investment interest is $7 million (0.21% of revenue), while product and customer allocation remains qualitative.
⚠️ Concerns
- •Known debt/assets is 30.15%, below examined 33.333% limits but sensitive to future filings
- •Distribution model and healthcare-product mix require qualitative review
- •Disclosed investment interest is 0.21% of quarterly revenue; no fixed purification percentage is asserted
- •Cash and short-term investments are reported together
- •Re-screen the financial ratios periodically
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-28; calculated 2026-07-15.
3,408 / 11,304
138 / 11,304
1,857 / 11,304
7 / 3,368
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 30.15%, liquidity/assets is 1.22%, receivables-plus-cash/assets is 16.43% and disclosed interest income/revenue is 0.21%; known ratios pass, while business disclosure remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Debt/assets, liquidity/assets and receivables-plus-cash/assets are below the examined MSCI limits; business disclosure remains incomplete.
- Financial
- Pass
- Overall
- Incomplete
Debt/assets is 30.15% and liquidity/assets is 1.22%, below the examined Malaysia limits; this is not an official classification.
- Financial
- Not calculated
- Overall
- Incomplete
A properly licensed and reproducible historical market-cap series is not stored; known asset-based ratios pass but business disclosure remains incomplete.
Business-activity disclosure
Henry Schein distributes healthcare products, equipment and services to dental and medical practices; healthcare distribution is generally permissible.
Limitation: The filing does not allocate revenue by downstream customer use or provide a universal prohibited-revenue numerator.
Purification
The filing discloses $7 million of investment interest (0.21% of revenue); treatment is disclosed for transparency, but no scholar-approved purification percentage is asserted.
Inputs, assumptions and primary sources
- Amounts are USD millions from Henry Schein's March 28, 2026 Form 10-Q.
- Debt combines short-term borrowings of $1,046 million and long-term debt and finance-lease obligations of $2,362 million.
- Cash and short-term investments are reported together at $138 million; no separate interest-bearing securities balance is identified in the primary balance sheet.
- Receivables use the reported net accounts-receivable balance of $1,719 million.
- Investment income interest of $7 million is disclosed (0.21% of quarterly revenue); healthcare distribution is generally permissible, while product/customer allocation remains qualitative.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
Similar Stocks
Want to screen more assets?
Use our interactive Halal Checker to screen any stock, ETF, or crypto instantly.
Go to Halal Checker →